Ferric Citrate Anhydrous

CHEMBL3991241 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
244.9 g/mol
LogP
Phase
4

This is a water-free form of ferric citrate, an iron-based phosphate binder used to manage elevated phosphate levels in patients with kidney disease. It also helps replenish iron stores as a secondary benefit during treatment.

Khối lượng phân tử

244,9400 g/mol

TPSA

141,00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Fe+3]

InChI

InChI=1S/C6H8O7.Fe/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+3/p-3

Molecular Formula

C6H5FeO7

HBD / HBA

1 / 7

Liên kết có thể quay

2

Nguyên tử nặng

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

This is a water-free form of ferric citrate, an iron-based phosphate binder used to manage elevated phosphate levels in patients with kidney disease. It also helps replenish iron stores as a secondary benefit during treatment.

Yes, Ferric Citrate Anhydrous is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3991241. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 61300. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.